3,979 Shares in Danaher Corporation $DHR Purchased by Continuum Advisory LLC

Continuum Advisory LLC bought a new stake in shares of Danaher Corporation (NYSE:DHR) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 3,979 shares of the conglomerate’s stock, valued at approximately $754,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of DHR. Bank Pictet & Cie Europe AG grew its position in Danaher by 25.4% in the fourth quarter. Bank Pictet & Cie Europe AG now owns 366,481 shares of the conglomerate’s stock worth $83,895,000 after acquiring an additional 74,301 shares in the last quarter. Maxi Investments CY Ltd bought a new position in Danaher in the third quarter valued at $3,251,000. Northwestern Mutual Wealth Management Co. raised its position in Danaher by 303.7% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock valued at $56,777,000 after purchasing an additional 186,584 shares in the last quarter. Defender Capital LLC. bought a new stake in Danaher during the fourth quarter worth about $35,715,000. Finally, CIBC Bancorp USA Inc. bought a new stake in Danaher during the third quarter worth about $17,480,000. 79.05% of the stock is currently owned by institutional investors.

Danaher Trading Down 1.6%

NYSE:DHR opened at $193.05 on Tuesday. The firm has a market capitalization of $136.63 billion, a P/E ratio of 37.34, a P/E/G ratio of 2.50 and a beta of 0.81. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. The company has a fifty day moving average of $178.81 and a 200 day moving average of $201.31. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80.

Danaher (NYSE:DHR) last released its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. The firm had revenue of $5.95 billion for the quarter, compared to analysts’ expectations of $6 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The company’s revenue for the quarter was up 3.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.88 earnings per share. On average, research analysts predict that Danaher Corporation will post 8.44 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Friday, June 26th. Danaher’s payout ratio is currently 30.95%.

Wall Street Analyst Weigh In

DHR has been the topic of a number of research reports. JPMorgan Chase & Co. decreased their price objective on Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a report on Wednesday, April 22nd. Guggenheim cut their price objective on shares of Danaher from $275.00 to $235.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. Evercore increased their target price on shares of Danaher from $225.00 to $232.00 and gave the company an “outperform” rating in a report on Tuesday, April 21st. HSBC decreased their target price on shares of Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a research report on Wednesday, June 3rd. Finally, Royal Bank Of Canada started coverage on shares of Danaher in a research note on Thursday, May 14th. They issued an “outperform” rating and a $200.00 price target for the company. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $233.61.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.